Target intelligence / Profile preview

Bacterial Carbohydrate-Binding Modules and Glycoside Hydrolases (CBMs and GHs)

Target
CBMs and GHs
Molecular classification
Enzyme, Carbohydrate-binding protein, Hydrolase
01

Overview

Bacterial Carbohydrate-Binding Modules (CBMs) and Glycoside Hydrolases (GHs) are essential components of the carbohydrate-active enzyme (CAZyme) apparatus used by bacteria to process complex sugars. Glycoside Hydrolases are enzymes responsible for the hydrolysis of glycosidic bonds, while CBMs are non-catalytic protein domains that increase catalytic efficiency by anchoring the enzyme to its carbohydrate substrate (Boraston et al., 2004). These proteins play a pivotal role in bacterial physiology, including nutrient acquisition, cell wall synthesis, and the formation of biofilms that protect bacteria from environmental stress and host immune responses (Davies & Henrissat, 1995). In clinical contexts, these molecules are significant targets for treating infections caused by pathogens such as Streptococcus pneumoniae and Pseudomonas aeruginosa, which utilize GHs to degrade host mucus and tissues (Koropatkin et al., 2012). Therapeutic interventions include the use of small-molecule inhibitors, such as iminosugars, which mimic the transition state of carbohydrate hydrolysis to block enzyme activity. Additionally, recombinant GHs are being explored as biofilm-dispersing agents that can break down the protective polysaccharide matrix of chronic infections, thereby enhancing the penetration and efficacy of standard antibiotics (Lombard et al., 2014).

Other names
Carbohydrate-Active EnzymesCAZymesGlycosidasesPolysaccharide-degrading enzymesBacterial glycosidases
02

Mechanism of action

Competitive inhibition of the catalytic active site of glycoside hydrolases or disruption of substrate binding via CBM interference.

03

Biological functions

Carbohydrate metabolismPolysaccharide degradationCell wall remodelingBiofilm formationNutrient acquisitionHost-pathogen interaction
04

Disease associations

InfectionBacterial pathogenesisCystic fibrosisDental cariesGastrointestinal disorders
05

Safety considerations

Cross-reactivity with human glycosidasesDisruption of the commensal gut microbiotaPotential for bacterial resistance
06

Interacting drugs

Acarbose

6 more in the full profile.

07

Biomarkers

Bacterial glycan degradation productsGH gene expression levelsBiofilm densityMetagenomic CAZyme profiles

Beyond the preview

Go deeper on Bacterial Carbohydrate-Binding Modules and Glycoside Hydrolases (CBMs and GHs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial Carbohydrate-Binding Modules and Glycoside Hydrolases (CBMs and GHs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call